Aureka is building a scalable internal pipeline of differentiated antibody therapeutics targeting cardiometabolic and inflammatorya diseases. Our data-driven AI platform supports high-throughput, function-first design, enabling the discovery of high-value antibodies that are otherwise inaccessible with conventional discovery methods.